The inflammatory myelinopathy of adreno-leukodystrophy: Cells, effector molecules, and pathogenetic implications

Journal of Neuropathology and Experimental Neurology

Volumn 51, Issue 6, 1992, Pages 630-643

  Powers, James M ^a   Liu, Yan ^a   Moser, Ann B ^b   Moser, Hugo W ^b  

^a Department of Orthopaedic Surgery   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Cytokines; Demyelination; Genetic; Immunity; Inflammation

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ADRENOLEUKODYSTROPHY; ARTICLE; ASTROCYTE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; EFFECTOR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

ADRENOLEUKODYSTROPHY; ADULT; B-LYMPHOCYTES; BRAIN; CELL ADHESION; CELL ADHESION MOLECULES; CHILD; COMPARATIVE STUDY; COMPLEMENT; DEMYELINATING DISEASES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-D ANTIGENS; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE-1; MACROPHAGES; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR;

EID: 0026469051     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/00005072-199211000-00007     Document Type: Article

References (41)

1. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch Neurol 1975;33:577-91
2. Poser CM. Diseases of the myelin sheath. In: Minckler J, ed. Pathology of the nervous system. Vol. 1. New York: McGraw-Hill, 1968:767-820
3. Moser HW, Naidu S, Kumar AJ, Rosenbaum AE. The adrenoleukodystrophies. Crit Rev Neurobiol 1987;3:29-88
4. Powers JM, Schaumburg HH. Adreno-leukodystrophy (sex-linked Schilder’s disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am J Pathol 1974;76:481-92
5. Schaumburg HH, Powers JM, Raine CS, et al. Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy. Neurology 1977;27:1114-19
6. Powers JM, Schaumburg HH, Johnson AB, Raine CS. A correlative study of the adrenal cortex in adrenoleukodystrophy. Evidence for a fatal intoxication with very long chain saturated fatty acids. Invest Cell Pathol 1980;3:353-76
7. Powers JM. Adreno-leukodystrophy (adreno-testiculo-leuko-myelo-neuropathic complex). Clin Neuropathol 1985;4:181-99
8. Griffin DE, Moser HW, Mendoza Q, Moench TR, O’Toole S, Moser AB. Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann Neurol 1985; 18:660-4
9. Bernheimer H, Budka H, Muller P. Brain tissue immunoglobulins in adrenoleukodystrophy. A comparison with multiple sclerosis and systemic lupus erythematosus. Acta Neuropathol 1983;59:95-102
10. Segal AH, Griffin DE, Moser AB, Moser HW, Ubol S. Immunological and biochemical comparison of childhood adreno-leukodystrophy (ALD) and adrenomyeloneuropathy (AMN). (Abstract) Neurology 1989;39(Suppl.):369-70
11. Naidu S, Bresnan MJ, Griffin D, O’Toole S, Moser HW. Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression. Arch Neurol 1988;45:846-8
12. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607-12
13. Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990;136:1309-16
14. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991;87:949-54
15. Powers JM, Liu Y, Hair L, Faust P, Moser A, Moser H. The inflammatory demyelinative lesion of adreno-leukodystrophy. (Abstract) J Neuropathol Exp Neurol 1992;51:381
16. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 1981;29:577-80
17. Sobel RA, Hafler DA, Castro EE, Morimoto C, Weiner HL. The 2H4(CD45R) antigen is selectively decreased in multiple sclerosis lesions. J Immunol 1988;140:2210-14
18. Achim CL, Schrier RD, Wiley CA. Immunopathogenesis of HIV encephalitis. Brain Pathol 1991;1:177-84
19. Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology. Philadelphia: W.B. Saunders, 1991
20. Boutin B, Matsuguchi L, Lebon P, Ponsot G, Arthuis C. Immunohistochemical analysis of brain macrophages in adrenoleukodystrophy. Neuropediatrics 1989;20:202-6
21. Yoshino T, Mukuzono H, Aoki H, et al. A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues. Am J Pathol 1989; 134: 1339-46
22. Sobel RA, Ames MB. Major histocompatibility complex molecule expression in the human central nervous system. Immunohistochemical analysis of 40 patients. J Neuropathol Exp Neurol 1988; 47:19-28
23. Plata-Salaman CR. Immunoregulators in the nervous system. Neurosci Biobehav Rev 1991;15:185-215
24. Jones EY, Stuart DI, Walker NPC. Structure of tumor necrosis factor. Nature 1989;338:225-8
25. Glynn P, Linington C. Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system. Crit Rev Neurobiol 1989;4:367-85
26. Cammer W, Brosnan CF, Basile C, Bloom BR, Norton WT. Complement potentiates the degradation of myelin proteins by plasmin. Implications for a mechanism of inflammatory demyelination. Brain Res 1986;364:91-101
27. Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DAS. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 1989;] 12:895-911
28. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merrill JE. Immunoregulatory molecules and IL-1 receptors identified in multiple sclerosis brain. J Immunol 1986; 136:3239-45
29. Beuscher HU, Nickells MW, Cohen HR. The precursor of interleukin-1 alpha is phosphorylated at residue serine 90. J Biol Chem 1988;263:4023-8
30. Tiffany CW, Hoefler S, Moser HW, Burch RM. Arachidonic acid metabolism in fibroblasts from patients with peroxisomal diseases. Response to interleukin 1. Biochim Biophys Acta 1991;1096:41-6
31. Cannella B, Cross AH, Raine CS. Adhesion-related molecules in the central nervous system. Lab Invest 1991;65:23-31
32. Jaattela M. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab Invest 1991;64:724-42
33. Robbins DS, Shirazi Y, Drysdale B-E, Lieberman A, Shin HS, Shin ML. Production of cytoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 1987;139:2593-7
34. Selmaj KW, Raine CS. Tumor necrosis factor mediated myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-46
35. Simmons RD, Willenborg DO. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J Neurol Sei 1990;100:37-42
36. Moser HW, Moser AB, Smith KD, et al. Adrenoleukodystrophy. Phenotypic variability. Implications for therapy. J Inher Metabol Dis (in press)
37. Lazo O, Contrevas M, Bhushan A, Stanley W, Singh I. Adrenoleukodystrophy. Impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Arch Biochem Biophys 1989; 270:722-8
38. Bizzozero OA, Zuniga G, Lees MB. Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders. J Neurochem 1991;56:872-8
39. Theda C, Moser AB, Powers JM, Moser HW. Phospholipids in X-linked adrenoleukodystrophy white matter. Fatty acid abnormalities before the onset of demyelination. J Neurol Sei (in press)
40. Wheat RW. Composition, structure, and biosynthesis of bacterial cell envelope and energy storage polymers. In: Joklik WK, et al, eds. Zinsser microbiology. Norwalk: Appleton & Lange, 1992:76-93
41. LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. Cytokine binding and clearance properties of proteinase-activated alpha 2-macrogIobulins. Lab Invest 1991:65:3-14